A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

NCT03006679 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Hospital-Acquired Bacterial Pneumonia
Ventilator-Associated Bacterial Pneumonia
Hospital-Acquired Pneumonia
Ventilator-Associated Pneumonia

Interventions

DRUG: Meropenem-Vaborbactam
DRUG: Piperacillin/Tazobactam

Sponsor

Melinta Therapeutics, Inc.